Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
New England Journal of Medicine · 11.04.2024 · 390 (14) · 1265-1276
DOI: 10.1056/nejmoa2310532 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 11.04.2024. Verfasst von Yi-Long Wu und 22 weiteren Autor:innen. Beteiligte Einrichtung: From the Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tyrosine Kinase Inhibitors, Platinum Compounds. Die Arbeit wurde bisher 463-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: F. Hoffmann-La Roche Ltd.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou (Y.-L.W., W.Z.), the Institute of Basic Medicine and Cance…
ORCID-Profile: Yi-Long Wu
Förderung
- F. Hoffmann-La Roche Ltd
Zitieren
APA
Wu, Y. L., Dziadziuszko, R., Ahn, J. S., Barlesi, F., Nishio, M., Lee, D. H., Lee, J. S., Zhong, W., Horinouchi, H., Mao, W., Hochmair, M., de Marinis, F., Migliorino, M. R., Bondarenko, I., Lu, S., Wang, Q., Ochi Lohmann, T., Xu, T., Cardona, A., …, & ALINA Investigators (2024). Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer. New England Journal of Medicine, 390(14), 1265-1276. https://doi.org/10.1056/nejmoa2310532
Vancouver
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, et al. Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer. New England Journal of Medicine. 2024;390(14):1265-1276. doi:10.1056/nejmoa2310532
BibTeX
@article{Wu2024,
author = {Wu, Yi-Long and Dziadziuszko, Rafal and Ahn, Jin Seok and Barlesi, Fabrice and Nishio, Makoto and Lee, Dae Ho and Lee, Jong-Seok and Zhong, Wenzhao and Horinouchi, Hidehito and Mao, Weimin and Hochmair, Maximilian and de Marinis, Filippo and Migliorino, M Rita and Bondarenko, Igor and Lu, Shun and Wang, Qun and Ochi Lohmann, Tania and Xu, Tingting and Cardona, Andres and Ruf, Thorsten and Noe, Johannes and Solomon, Benjamin J and ALINA Investigators, ALINA Investigators},
title = {Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer},
journal = {New England Journal of Medicine},
year = {2024},
volume = {390},
number = {14},
pages = {1265--1276},
doi = {10.1056/nejmoa2310532}
}
EUVIMED